Late-stage clinical development programs in gynecologic oncology. Contributions to protocol strategy, safety review, regulatory submission support, and scientific communication across Phase 1/2 oncology trials including OPAL and POLQi (GSK4524101) programs. Inclusion & Diversity Champion, GSK Oncology — Boston–Waltham–Cambridge.

Physician-led medical device company developing a portfolio of three FDA-cleared device programs addressing unmet needs in women's pelvic health: Belotte Colpotomizer™ (surgical access), POP-Q AutoSense™ (pelvic diagnostics), and Pudendal Nerve Block Device™ (interventional). Raising Post-Money SAFE at $5M valuation cap; pursuing NIH STTR funding and Series Seed institutional financing.

Vertically integrated women's health practice delivering evidence-based, patient-centered gynecologic care. Six operational pillars: clinical patient care, research & development, education & training, consulting & advisory, community engagement, and medical device innovation.

Healthcare strategy, financial modeling, organizational design, health policy, and entrepreneurship. Thesis-level training in healthcare economics and strategic leadership.

Dissertation: Molecular mechanisms of cisplatin chemoresistance in epithelial ovarian cancer; oxidative stress, antioxidant enzyme single nucleotide polymorphisms, and redox signaling pathways. Mentors: Ghassan M. Saed, PhD; Michael P. Diamond, MD.

One of the nation's leading urban academic medical systems for OB/GYN training. Training encompassed general gynecology, minimally invasive surgery, gynecologic oncology, maternal-fetal medicine, and urogynecology.

Competitive NIH T32 training award for physician-scientists pursuing research in women's reproductive health. One of a select cohort of US OB/GYN physician-scientists with active NIH-funded training.

Training at the highest level of gynecologic oncology available in the United States. Invited lecture: "Management of Bowel Obstruction in the Setting of Ovarian Cancer" (May 2010).

Department of Obstetrics, Gynecology & Women's Health. Grand Rounds: Cervical Cancer Screening (August 2018); Invited Research Lecture on Cisplatin Resistance (September 2017).

Research program: oxidative stress and antioxidant enzyme polymorphisms in epithelial ovarian cancer chemoresistance. Laboratory of Ghassan M. Saed, PhD and Michael P. Diamond, MD.

Grand Rounds lecturer: "Vaccines for Women's Health: An Update for the Obstetrician/Gynecologist" — Wayne State School of Medicine OB/GYN, Harper/Hutzel Hospital (May 2, 2017); also St. John Hospital & Medical Center (March 2017).

Reusable handle / single-use disposable crown system for automated 360° electrosurgical colpotomy in laparoscopic hysterectomy. Asymmetric blade geometry, integrated balloon insufflation, microprocessor-regulated energy delivery, motor-assisted rotation. FDA Class II · 510(k) pathway.

Sensorized conformable anatomical vaginal sleeve with indexed ring electronics — simultaneous measurement of all nine POP-Q reference points with digital twin 3D visualization and HL7 FHIR EMR export. SaMD classification applicable. FDA 510(k) + De Novo pathway.

Finger-mounted modular system integrating PMUT ultrasound ring array, near-infrared optical sensing, and spring-loaded disposable needle delivery — single-operator nerve localization and vascular avoidance for pudendal nerve block. FDA Class II · 510(k) pathway.